A jury in Washington state this week ordered one of the world鈥檚 largest pharmaceutical companies to pay more than $850 million to a small group of parents and children after finding that they suffered exposure to highly toxic chemicals in a school building.
The lawsuit concerns the Sky Valley 91制片厂视频 Center, part of the school district in Monroe, Wash. Dozens of adults and children have said they experienced debilitating illnesses after spending time there during the 2010s.
On Dec. 19, a jury in King County Superior Court ordered Bayer, which owns the company that manufactured the chemicals in question, to pay $73 million in compensatory damages and an additional $784 million in punitive damages to seven parents and children who were exposed at Sky Valley.
Several more trials pitting Sky Valley staff and families against Bayer over PCB contamination will play out in state court in the coming years.
Investigators in Sky Valley identified high levels of polycarbonate biphenyls or PCBs, a set of chemical compounds the federal government banned in the late 1970s from being manufactured in the United States. 91制片厂视频 Week reported extensively last year on the presence of these chemicals in hundreds of school buildings nationwide.
PCBs were initially used as sealants to strengthen the lifespan of building materials. But prolonged exposure to PCBs, which can seep from paint and caulk into the air, can lead to a wide range of health effects, from headaches and trouble breathing to cancer and other long-term diseases.
Monsanto, which Bayer acquired in 2016, was the main manufacturer of PCBs in this country. The company has denied culpability and vowed to challenge all cases involving allegations of PCB exposure in schools.
In a statement this week, the company blasted the latest round of damages as 鈥渃onstitutionally excessive鈥� and said it plans to seek to overturn the verdict. The company contends that the school district was responsible for heeding warnings in the 1990s to address PCB-laden light fixtures that may have posed a threat.
Monsanto is facing legal challenges from multiple states over PCBs in schools
Gerry Pollet, a Washington state senator and a professor of public health at the University of Washington, told 91制片厂视频 Week he found the latest verdict 鈥渟tunning.鈥�
鈥淭he punitive figure clearly indicates that the jury believed that Monsanto and its spinoff did not act responsibly,鈥� he said.
Pollet said he hopes the latest verdict will spur his lawmaker colleagues to support overturning a longstanding but obscure budget item that prevents the state board of health from revising its guidance on measures schools should take to protect community health.
鈥淲e know that Monroe/Sky Valley is not the sole, isolated potential exposure amongst schools in Washington,鈥� Pollet said.
Lawsuits against Monsanto over the fallout from PCB exposure at Sky Valley have been playing out in court for years. Prior to this week鈥檚 ruling, juries have already to more than two dozen former school employees, parents, and students affected by PCB contamination at the school.
The worth $34 million in 2022.
Monsanto is also facing legal scrutiny over PCBs in schools in Vermont, where the legislature launched a statewide search for PCBs in school buildings constructed before PCB manufacturing was outlawed.
Numerous schools have shut down portions of their buildings and shelled out thousands of dollars when PCBs have turned up.
Most notably, Burlington High School closed its doors in 2020 upon receiving PCB findings that prompted the statewide investigation. Students and teachers shifted to classrooms at a former Macy鈥檚 department store nearby, where they remain to this day.
A new permanent building is . The , arguing the company should cover the costs of construction.
The state of Vermont also sued Monsanto earlier this year, arguing the company should cover the costs of those mitigation efforts. A coalition of a month later, but the state鈥檚 attorney general has since asked schools to to avoid duplicating efforts.
The Sky Valley saga in Washington, meanwhile, is far from over. Close to two dozen additional trials are set to unfold in the coming years.
